Quality improvement is central to achieving high-value care. Learn how we collaborate with all industry stakeholders to identify and bridge measurement gaps and advance patient care.
Avalere and Mental Health America (MHA) developed a white paper to describe the current state of quality of care for individuals with major depressive disorder (MDD), provide an evidence-based assessment of challenges, and highlight potential opportunities for quality improvement.
While Medicare Access and CHIP Reauthorization Act or MACRA seeks to stabilize Medicare and assure physicians a predictable stream of revenue given a schedule of expected physician payment updates, how can providers leverage MACRA to improve quality of care? Listen in as Kristi Mitchell suggests how providers can use MACRA as a springboard to develop and implement relevant quality measures to close the current measurement gaps across disease conditions and care settings.
The ACA is built on a foundation of improving the quality of care for all patients and includes a number of provisions to help consumers make decisions about where to receive their care as well as how to increase the transparency of services through value-based purchasing efforts and private sector programs. Listen in as Nelly Ganesan discusses the trend of using value-based systems in quality reporting programs which will require physicians to focus on outcomes versus processes.
In recognition of National Healthcare Quality Week, we sat down with Avalere expert Nelly Ganesan to discuss upcoming trends and developments for physician quality measurement.
Despite evidence demonstrating the benefits of optimal nutrition for healing and recovery, practice variation continues in hospitals for nutrition screening, assessment, diagnosis, and overall treatment and management of malnourished adults ages 65 and older. In response, Avalere launched the Malnutrition Quality Improvement Initiative (MQII) to support the delivery of high-quality care for older adults. The MQII not only aims to support the use of timely best practices for malnutrition care in the hospital setting but may also reduce costs associated with poor patient outcomes.
A new white paper from Avalere finds wide variation in how organizations develop and use clinical pathways (CPs)-multidisciplinary plans that provide specific guidance on the sequencing of care steps and the timeline of interventions. While CPs have the potential to improve quality and reduce cost, their growing use prompts a range of questions and concerns from patient advocates and healthcare providers. Specifically, Avalere's new work examines the lifecycle of a CP and explores the potential implications of growing use of these tools for payers, providers, and patients.
Avalere recently partnered with Third Way to estimate the cost savings of increasing medication adherence among Medicare beneficiaries by improving and expanding the current Part D Medication Therapy Management (MTM) program to target and address adherence issues for specific conditions.
A new Avalere assessment of the quality measures landscape shows that many important medical conditions are not fully represented in Medicare pay-for-quality programs, which limits Medicare's ability to pay for value.
Cancer is a burden to patients and the healthcare system. Last year, an estimated 1.6 million new cancer cases were diagnosed in the U.S and the latest figures estimate that 13.4 million people, about 4 percent of the U.S. population, live with cancer in the U.S.1
Achieving a vision of patient-centered healthcare requires multi-stakeholder collaboration each step of the way. As national attention on the use of patient-reported outcomes (PROs) grows, significant progress needs to be made to ensure that they are fairly used for accountability purposes in the context of performance-based payment models.
Avalere Health led the Pharmacy Quality Alliance's February 2015 Quality Forum Lecture entitled: A Look Ahead at 2015.
As healthcare leaders and policymakers look to curb spending and improve quality, they should examine models like the Alternative Quality Contract (AQC), according to a new paper by Avalere.
Avalere published an article this week on ASCO's plan to launch CancerLinQ™.
Despite its notable negative impact on patient outcomes and costs of care, malnutrition is an area that has largely remained unaddressed by national programs and initiatives.
In 2015, Avalere Health and the Center for Medical Technology Policy will work together to develop the Partnership for Enhanced Recovery to promote broader adoption of proven protocols in the surgical space across a number of US hospitals.
Listen to Avalere's Debbie Lucas explain the complex world of quality measurement.
In the Calendar Year (CY) 2015 End Stage Renal Disease (ESRD) Prospective Payment System (PPS) final rule released on October 31, the Centers for Medicare & Medicaid Services (CMS) finalized a 2015 base per treatment rate of $239.43, up slightly from $239.02 in CY 2014.
"On June 10, 2014, the Center for Medical Technology Policy (CMTP) in collaboration with Avalere Health hosted a multi-stakeholder forum in Baltimore, Maryland, to discuss potential challenges and opportunities to accelerate the adoption of enhanced recovery protocols (ERPs) in the U.S.
Listen to Debbie Lucas discuss how quality measurement can lead to improvements in the quality of care and the impact on providers.
The use of quality and performance measures in public reporting, value-based purchasing, and alternative payment models is altering clinical practice by providing incentives to improve quality measures performance and provide high-value care. Debbie Lucas helps many stakeholders seek to understand these measures, assess their business impacts, and use the information to guide decision-making.